BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 12436438)

  • 21. Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatment.
    Huland E; Heinzer H; Huland H
    J Cancer Res Clin Oncol; 1994; 120(4):221-8. PubMed ID: 8288676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of recombinant interferon alpha-2C in metastatic renal cell carcinoma.
    Scheithauer W; Kuehrer I; Kutzmits R; Dittrich C; Steger G; Flener R; Ludwig H
    J Biol Regul Homeost Agents; 1987; 1(2):81-6. PubMed ID: 3504086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation.
    Joffe JK; Banks RE; Forbes MA; Hallam S; Jenkins A; Patel PM; Hall GD; Velikova G; Adams J; Crossley A; Johnson PW; Whicher JT; Selby PJ
    Br J Urol; 1996 May; 77(5):638-49. PubMed ID: 8689103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous alpha-interferon.
    Besana C; Borri A; Bucci E; Citterio G; Di Lucca G; Fortis C; Matteucci P; Tognella S; Tresoldi M; Baiocchi C
    Eur J Cancer; 1994; 30A(9):1292-8. PubMed ID: 7999416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma.
    Mittelman A; Huberman M; Puccio C; Fallon B; Tessitore J; Savona S; Eyre R; Gafney E; Wick M; Skelos A
    Cancer; 1990 Aug; 66(4):664-9. PubMed ID: 2386896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interferon therapy for advanced renal cell carcinoma].
    Fujita T; Fukushima M
    Hinyokika Kiyo; 1992 Nov; 38(11):1293-8. PubMed ID: 1485584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma.
    Atzpodien J; Lopez Hänninen E; Kirchner H; Bodenstein H; Pfreundschuh M; Rebmann U; Metzner B; Illiger HJ; Jakse G; Niesel T
    J Clin Oncol; 1995 Feb; 13(2):497-501. PubMed ID: 7844611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma.
    Atkins MB; Sparano J; Fisher RI; Weiss GR; Margolin KA; Fink KI; Rubinstein L; Louie A; Mier JW; Gucalp R
    J Clin Oncol; 1993 Apr; 11(4):661-70. PubMed ID: 8478661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interferon and interleukin 2 in metastatic cancer of the kidney. Apropos of 18 cases].
    Boaziz C; Breau JL; Morère JF; Raymond E; Moliard M; Israel L
    Ann Urol (Paris); 1991; 25(4):163-7. PubMed ID: 1746923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancer.
    Sella A; Kilbourn RG; Gray I; Finn L; Zukiwski AA; Ellerhorst J; Amato RJ; Logothetis CJ
    Cancer Biother; 1994; 9(2):103-11. PubMed ID: 7812360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II study of interferon alpha and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma.
    Piga A; Giordani P; Quattrone A; Giulioni M; De Signoribus G; Antognoli S; Cellerino R
    Cancer Immunol Immunother; 1997 Aug; 44(6):348-51. PubMed ID: 9298938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2: a single-center phase II study.
    Geertsen PF; Hermann GG; von der Maase H; Steven K
    J Clin Oncol; 1992 May; 10(5):753-9. PubMed ID: 1569448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.
    Fyfe G; Fisher RI; Rosenberg SA; Sznol M; Parkinson DR; Louie AC
    J Clin Oncol; 1995 Mar; 13(3):688-96. PubMed ID: 7884429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up.
    Minasian LM; Motzer RJ; Gluck L; Mazumdar M; Vlamis V; Krown SE
    J Clin Oncol; 1993 Jul; 11(7):1368-75. PubMed ID: 8315435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma.
    Sparano JA; Fisher RI; Sunderland M; Margolin K; Ernest ML; Sznol M; Atkins MB; Dutcher JP; Micetich KC; Weiss GR
    J Clin Oncol; 1993 Oct; 11(10):1969-77. PubMed ID: 8410122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An outpatient phase I study of a subcutaneous interleukin-2 and intramuscular alpha-2a-interferon combination in advanced malignancies.
    Rosso R; Sertoli MR; Queirolo P; Sanguineti O; Barzacchi MC; Mariani GL; Miglio L; Venturini M; Toma S
    Ann Oncol; 1992 Jul; 3(7):559-63. PubMed ID: 1498078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-alpha, 5-FU and prednisone in metastatic renal cell carcinoma: a phase II study.
    Haarstad H; Jacobsen AB; Schjølseth SA; Risberg T; Fosså SD
    Ann Oncol; 1994 Mar; 5(3):245-8. PubMed ID: 8186172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination therapy with recombinant interferon alpha-21 (rIFN alpha 2a) and recombinant interleukin 2 (rIL-2) in metastatic renal cell cancer].
    Jurincic-Winkler C; Horlbeck R; Klippel KF
    Wien Klin Wochenschr; 1993; 105(10):271-6. PubMed ID: 8517056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A direct comparison of immunological and clinical effects of interleukin 2 with and without interferon-alpha in humans.
    Schiller JH; Hank J; Storer B; Borchert AA; Moore KH; Albertini M; Bechhofer R; Wesley O; Brown RR; Bastin AM
    Cancer Res; 1993 Mar; 53(6):1286-92. PubMed ID: 8443808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous intravenous interleukin-2 infusion and subcutaneous interferon-alpha in metastatic renal cell carcinoma.
    Fosså SD; Aune H; Baggerud E; Granerud T; Heilo A; Theodorsen L
    Eur J Cancer; 1993; 29A(9):1313-5. PubMed ID: 8343275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.